3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Adenocarcinoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
HER2-positive Breast Cancer
1
Cystic Fibrosis
1
Breast Neoplasms
1
Interventions
Gemcitabine
7
130-nm albumin-bound paclitaxel
5
Fluorouracil
3
Albumin-Bound Paclitaxel
3
dehydroftorafur
2
Taxes
2
Oxaliplatin
2
tocilizumab
1
selicrelumab
1
niraparib
1
cobimetinib
1
atezolizumab
1
Tiragolumab
1
Resistance Training
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Pancreatectomy
1
PEGPH20
1
Nivolumab
1
Leucovorin
1
Irinotecan
1
Ipilimumab
1
Interleukin 1 Receptor Antagonist Protein
1
Erlotinib Hydrochloride
1
Electronic Health Records
1
Cisplatin
1
Bevacizumab
1
4-fluorobenzoyl-TN-14003
1
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pancreatic Adenocarcinoma
×
Electronic Health Records
×
Clear all
NCT04406571
2024-01-24
CAPANCOVID-19
CHU de Reims
Completed
700 enrolled